Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

349
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
349
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

246
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
246
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.8K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.8K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.1K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

327
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
327
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

266
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
266

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of habits, triggers, glycaemic control, routines, stress and impulse control among emerging adults with type 1 diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2020
Same author

Effect of a diabetes order set on glycaemic management and control in the hospital.

Quality & safety in health care·2008
Same author

Use of a standardized protocol to decrease medication errors and adverse events related to sliding scale insulin.

Quality & safety in health care·2006
See all related articles

Related Experiment Video

Updated: Sep 4, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.9K

Pharmacist Role in Providing Inpatient Diabetes Management.

J T Knezevich1, A C Donihi2, A T Drincic3

  • 1Department of Pharmaceutical and Nutrition Care, 984120 Nebraska Medical Center, University of Nebraska Medical Center, Omaha, NE, 68198-4120, USA. jknezevich@nebraskamed.com.

Current Diabetes Reports
|July 13, 2022
PubMed
Summary

Pharmacists are vital for improving hospital glycemic management. Their leadership in interdisciplinary teams enhances patient outcomes and achieves glycemic targets effectively.

Keywords:
Acute glycemic managementCollaborative practice agreementDiabetes educationDiabetes stewardshipInpatient diabetes managementPharmacistPharmacist consultantPharmacy models of care

More Related Videos

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

343
Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
05:06

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise

Published on: July 14, 2023

1.8K

Related Experiment Videos

Last Updated: Sep 4, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.9K
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

343
Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
05:06

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise

Published on: July 14, 2023

1.8K

Area of Science:

  • Healthcare Management
  • Clinical Pharmacy
  • Patient Safety

Background:

  • Hospital glycemic management is a significant challenge.
  • Achieving glycemic targets improves patient clinical outcomes.
  • Interdisciplinary teams are essential for successful glycemic control.

Purpose of the Study:

  • To summarize data on improved patient outcomes with pharmacist-led glycemic management.
  • To describe pharmacy stewardship models for institutional glycemic oversight.
  • To highlight the pharmacist's role in acute care glycemic management.

Main Methods:

  • Review of published literature on pharmacist interventions in glycemic management.
  • Analysis of patient-directed intervention models.
  • Description of pharmacy stewardship implementation and its impact.

Main Results:

  • Pharmacist involvement in patient-directed models improves glycemic control.
  • Pharmacy stewardship effectively shapes institutional practices for better glycemic management.
  • Pharmacists demonstrate versatility in various care models.

Conclusions:

  • Pharmacists are uniquely positioned to lead glycemic management initiatives.
  • Pharmacy-led interventions and stewardship enhance patient outcomes and institutional performance.
  • Integrating pharmacists into care models is crucial for optimizing acute glycemic management.